Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Reduce the proportion of adults with chronic kidney disease who have elevated blood pressure — CKD‑06 Data Methodology and Measurement

On this page:  About the National Data  |  Methodology  |  History

About the National Data

Data

Data Source:  National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

Baseline: 44.8 percent of adults aged 18 years and over with chronic kidney disease had elevated blood pressure in 2013-16

Target: 39.8 percent

Numerator
Number of adults aged 18 years and over with chronic kidney disease stages 1–4 with measured high systolic (≥130 mmHg) or diastolic (≥80 mmHg) blood pressure.
Denominator
Number of adults aged 18 years and over with chronic kidney disease stages 1–4 who have blood pressure measurements.
Target-setting method
Minimal statistical significance
Target-setting method details
Minimal statistical significance, assuming the same standard error for the target as for the baseline.
Target-setting method justification
Trend data were not available for this objective. The standard error was used to calculate a target based on minimal statistical significance, assuming the same standard error for the target as for the baseline. This method was used because the target is a statistically significant improvement from the baseline. This conservative target was selected because of the lower threshold definition of high blood pressure in the more recent patient care recommendations.

Methodology

Methodology notes

Chronic kidney disease (CKD) stages 1–4 are defined as a urinary albumin-to-creatinine ratio (ACR) ≥ 30 mg/g (single measurement) or estimated glomerular filtration rate (eGFR) between 15 and 59 ml/min/1.73 m². The eGFR is computed using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.

Adults are defined as having high blood pressure if they have a measurement of mean systolic blood pressure ≥ 130 mm Hg or mean diastolic blood pressure ≥ 80 mm Hg. Blood pressure is measured by averaging up to 3 blood pressure readings taken during the physical examination in the NHANES Mobile Examination Center. A detailed description of the procedures for blood pressure measurement in the NHANES has been published elsewhere.

Age-adjustment notes

This Indicator uses Age-Adjustment Groups:

  • Total: 18-44, 45-64, 65+
  • Sex: 18-44, 45-64, 65+
  • Race/Ethnicity: 18-44, 45-64, 65+
  • Educational Attainment: 25-44, 45-64, 65+
  • Family Income (percent poverty threshold): 18-44, 45-64, 65+
  • Country of Birth: 18-44, 45-64, 65+
  • Disability Status: 20-44, 45-64, 65+
  • Health Insurance Status: 18-44, 45-64
  • Marital Status: 20-44, 45-64, 65+
  • Veteran Status: 18-44, 45-64, 65+
  • Obesity Status: 20-44, 45-64, 65+

History

Comparable HP2020 objective
Modified, which includes core objectives that are continuing from Healthy People 2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People objective CKD-6.1 in that objective CKD-6.1 tracked persons with chronic kidney disease stages 1-4 with measured systolic (≥ 140 mmHg) or diastolic (≥ 90mmHg) blood pressure, while this objective tracks persons with chronic kidney disease stages who had measured systolic (≥ 130mmHg) or diastolic (≥ 80 mmHg) blood pressure. In 2023, the objective has been modified due to changes to 2021 race free, serum creatine only CKD-EPI equation used to determine estimated glomerular filtration rate (eGFR).
Revision History
Revised. 

In 2023, the original baseline was revised from 46.6 to 44.8 percent due to changes to 2021 race free, serum creatine only CKD-EPI equation used to determine estimated glomerular filtration rate (eGFR). The target was adjusted from 42.8 to 39.8 percent to reflect the revised baseline using the original target-setting method.